This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

American Express, Boeing, 5 Others Are Dragging Down the Dow 30

The short-term reversion to the mean is the 200-day simple moving average at 16322. There are 12 Dow 30 components that ended Friday below their 200-day SMAs and seven have underperformed the Dow since July 3.

Let's compare the performances of these seven since my July 7 post covering the Dow 30 pre-earnings. Note that the Dow is down 3.4% since July 3.

American Express (AXP - Get Report) ($86.47) is down 9.8% since July 3 and set an all-time intraday high at $96.24 on July 1 with its 200-day simple moving average at $88.56. The weekly chart was positive but overbought on July 3 but is now negative with its five-week MMA at $91.81. A semiannual value level is $83.59 with weekly and monthly risky levels at $90.53 and $93.78, respectively.

Boeing (BA) ($120.38) is down 6.3% since July 3 and has been below its 200-day SMA at $130.52 since June 25. The weekly chart remains negative with its five-week MMA at $126.84. A weekly value level is $116.44 with semiannual and monthly risky levels at $122.99 and $123.60, respectively.

General Electric (GE) ($25.35) is down 5.6% since July 3 and has been below its 200-day SMA at $26.32 since July 21. The weekly chart is negative with its five-week MMA at $26.24. Annual value levels are $16.89 and $16.11 with a weekly pivot at $25.52 and monthly and semiannual risky levels at $26.10 and $26 94, respectively.

Coca Cola (KO) ($39.29) is down 7% since July 3 after setting its 2014 intraday high at $42.57 on July 21. The stock closed below its 200-day SMA at $39.89 on July 30. The weekly chart was positive but overbought on July 3 and is now negative with its five-week MMA at $41.04 and its 200-week SMA at $36.88. An annual value level is $38.28 with a monthly pivot at $39.33 and quarterly and weekly risky levels at $40.35 and $41.49, respectively.

McDonald's (MCD - Get Report) ($94.30) is down 6.6% since July 3 after breaking below its 200-day SMA at $97.80 on July 21. The weekly chart remains negative with its five-week MMA at $98.56 and its 200-week SMA at $91.55. A weekly pivot is $95.58 with monthly and annual risky levels at $97.93 and $99.30, respectively.

Pfizer (PFE) ($28.86) is down 5.5% since July 3 and has been below its 200-day SMA at $30.75 since July 21. The weekly chart is negative with its five-week MMA at $29.88. An annual value level is $24.86 with semiannual and monthly pivots at $28.66 and $29.07 and weekly, quarterly and semiannual risky levels at $30.18, $34.31 and $35 56, respectively.

Read More: Dodge to Tesla: Eat Your Heart Out

United Technologies (UTX) ($104.75) is down 9.3% since July 3 and has been below its 200-day SMA at $113.41 since July 22. The weekly chart remains negative with its five-week MMA at $112.33 and its 200-week SMA at $89.81. Annual value levels are $103.38 and $92.88 with semiannual and weekly pivots at $105.86 and $106.72, respectively, and monthly and semiannual risky levels at $117.29 and $122.52, respectively.

At the time of publication, the author held no positions in any of the stocks mentioned, although positions may change at any time.

Follow @Suttmeier

This article is commentary by an independent contributor, separate from TheStreet's regular news coverage.

2 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Try it NOW
Only $9.95
Try it NOW
14-Days Free
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
SYM TRADE IT LAST %CHG
AXP $77.97 0.00%
MCD $96.96 0.00%
AAPL $123.25 0.00%
FB $83.30 0.00%
GOOG $548.34 0.00%

Markets

DOW 17,712.66 +34.43 0.19%
S&P 500 2,061.02 +4.87 0.24%
NASDAQ 4,891.2190 +27.8570 0.57%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs